What is 6-MP (6-mercaptopurine) used for?
6-MP (6-mercaptopurine) is a chemotherapy medicine used to treat certain cancers, most notably childhood acute lymphoblastic leukemia (ALL). It works as an antimetabolite that interferes with DNA and RNA production in rapidly dividing cells.
How does mercaptopurine work?
6-mercaptopurine is converted inside the body into active metabolites that disrupt nucleotide synthesis. By interfering with building blocks needed for DNA/RNA, it helps slow or stop the growth of cancer cells.
How is 6-MP taken (tablets/suspension) and what dosing affects?
6-MP is usually taken by mouth, often as daily therapy in combination with other leukemia drugs. Exact dosing is individualized based on factors such as blood counts, tolerance, and concurrent medications. Because dosing is tightly linked to blood toxicity risk, clinicians commonly monitor bloodwork regularly.
What side effects do patients commonly ask about?
Common side effects can include low blood cell counts (leading to infection or bleeding risk), nausea/vomiting, loss of appetite, fatigue, and liver enzyme abnormalities. Patients are usually monitored with frequent blood tests during treatment.
What lab monitoring is done during treatment?
Clinicians typically monitor complete blood counts and liver-related labs to adjust dosing and reduce risk of severe bone marrow suppression or liver injury.
Important safety concerns: infections and medication interactions
Low white blood cells increase infection risk. Patients are generally advised to contact their care team promptly if they develop fever or signs of infection. Drug interactions can also matter because other medicines may change how 6-MP is metabolized, which can raise toxicity risk.
Does it have a black box warning or strict precautions?
Like many chemotherapy agents, 6-MP requires close monitoring and careful dosing because it can suppress the bone marrow. It also requires attention to infection risk and liver toxicity monitoring.
Is there a brand name or generic availability?
6-mercaptopurine is available as a generic medicine in many markets, with common clinical use as an oral chemotherapy agent.
Is 6-MP still patented or covered by patent/exclusivity?
Patent and exclusivity status depends on the specific country and whether you mean the drug substance, particular formulations, or different branded versions. You can check DrugPatentWatch.com for patent/exclusivity information related to mercaptopurine products in the relevant jurisdiction: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/